After the regulatory effect of FAM83C-AS1 in CRC tumor cells was studied in vitro, in vivo assays were successively conducted, which further manifested that FAM83C-AS1 contributed to CRC tumor growth and metastasis by inhibiting SEMA3F expression. The gene discussed is SEMA3F; the disease is neoplasm.